Curis Inc (NASDAQ:CRIS) - Share price - Overview

Stock Report

Curis Inc CRIS

Last Price
$2.83

Day Change
0.03|1.07%

As of 22/03/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close2.80
Day Range2.69 - 2.85
Mkt Cap-
52-Wk Range1.42 - 3.72
Yield %-
ISINUS2312691015
Volume409,821
P/E-6.29
P/S49.48
P/CF-10.49

Share Price

Financials
201420152016
More ...
Income Statement
Revenue9.847.887.53
Operating Income-15.86-56.48-58.04
Net Income-18.73-58.98-60.41
Basic EPS-0.22-0.48-0.45
Avg. Diluted Shares Outstanding86123133
Balance Sheet
Current Assets52.2185.5048.20
Non Current Assets10.409.469.55
Total Assets62.6194.9757.75
Current Liabilities10.0710.7613.55
Total Liabilities32.8330.4528.49
Total Equity29.7864.5129.27
Cash Flow
Operating Cash Flow-16.81-29.89-35.81
Capital Expenditure-0.09-0.05-0.33
Free Cash Flow-16.90-29.94-36.14

In millions, except "Basic EPS". Currency is USD.

Company Profile

Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its products include CUDC-907, phosphatidylinositol-3-kinase and small molecule inhibitor of histone deacetylase.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

58
Key Stats
More ...
Price/Earning TTM-6.22
Price/Book13.57
Price/Sales TTM50.09
Rev Growth (3 year avg)-20.54
EPS Growth (3 year avg)-
Operating Margin % TTM-771.08
Net Margin % TTM-802.59
ROE TTM-128.84
Debt/Equity0.51
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.